EVEREST MEDICINES Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for EVEREST MEDICINES with the United States Patent and Trademark Office. The USPTO has given the EVEREST MEDICINES trademark a serial number of 98416690. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 11, 2025. This trademark is owned by Everest Medicines (Singapore) Pte. Ltd.. The EVEREST MEDICINES trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for health care, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, de...

Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; active chemical substances for use in the production of drugs for treating and preventing nephropathy, bacterial infection, cancer, gastrointestinal inflammation.
everest medicines

General Information


Serial Number98416690
Word MarkEVEREST MEDICINES
Filing DateThursday, February 22, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for health care, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal.
Goods and ServicesActive chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; active chemical substances for use in the production of drugs for treating and preventing nephropathy, bacterial infection, cancer, gastrointestinal inflammation.
NOT AVAILABLEMEDICINES

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEverest Medicines (Singapore) Pte. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressSingapore 049712
SG

Party NameEverest Medicines (Singapore) Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSingapore 049712
SG

Trademark Events


Event DateEvent Description
Friday, June 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2024NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024NEW APPLICATION ENTERED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Wednesday, September 11, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT